RITA DEXTER: Open Payments
NPI 1538792007 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 5 payments from 4 companies in 2025. Trend: 2023 $58 · 2024 $169 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: COBENFY, AUSTEDO XR, CAPLYTA, REXULTI.
Industry payments across MD — which companies pay providers there.
